Innovation Switzerland Innovation Parks Switzerland Innovation’s technology parks are the ideal location for research-oriented companies to develop their next groundbreaking or highly p...
Aktuell May 19, 2023 Helisul kauft Jedsy-Drohnen für bis zu 26 Millionen Dollar Die brasilianische Helisul Aviação will sich in ihrem Land mithilfe der Gleiter und Andockstationen des St.Galler Unternehmens Jedsy als führende...
Actualités Oct 19, 2023 Nouveaux fonds pour le traitement de régénération tissulaire de Mimix Biotherapeutics La société biennoise Mimix Biotherapeutics a annoncé la clôture d’un important tour d’investissement, auquel ont participé des investisseurs euro...
News Apr 23, 2024 Swibrace advances to clinical phase with innovative 3D-printed wrist braces Swibrace, in partnership with the Inselspital in Bern, moves its customized wrist braces into clinical phase, enhancing fracture treatment throug...
成功談 Dec 12, 2023 「最初の選択肢はスイスでしたし、これからもスイスであり続けます」 M&K Global AGはドローンサービスの統合戦略、実社会への導入、教育に注力する、ベルンを拠点とするホールディングカンパニーです。M&K Global AGはスイスで3年半の間に、1人体制だった運営から18人の組織に成長を遂げました。
Actualités Apr 23, 2024 Les orthèses de poignet innovantes imprimées en 3D de Swibrace passent à la phase clinique Swibrace, en partenariat avec l’Inselspital de Berne, fait passer ses attelles de poignet personnalisées en phase clinique, améliorant ainsi le t...
News Oct 12, 2023 Jedsy enters into multi-million dollar contract with Asklepios Drone manufacturer Jedsy, based in the St.GallenBodenseeArea, has entered into a large delivery contract with German hospital group Asklepios. Th...
成功故事 Dec 12, 2023 “无论是过去或未来,我们的首选永远是瑞士" M&K Global AG 是一家总部位于瑞士首都伯尔尼的控股公司,专注于无人机服务集成、现实世界行业应用和相关教育战略。瑞士的 M&K Global AG 在 3 年半的时间里,从一个人运营成长为18人的组织。
News May 19, 2023 Helisul buys Jedsy drones for up to $26 million Brazilian company Helisul Aviação is seeking to establish itself as a leading provider of drone delivery services in Brazil, with the help of gli...
Innovation Switzerland Innovation Parks Switzerland Innovation’s technology parks are the ideal location for research-oriented companies to develop their next groundbreaking or highly p...
Actualités Jan 12, 2022 ObsEva obtient des résultats positifs dans le traitement de l’endométriose Spécialisée dans la santé des femmes, la société biopharmaceutique genevoise ObsEva a annoncé des résultats préliminaires positifs de l'essai de ...
Innovation Switzerland Innovation Parks Switzerland Innovation’s technology parks are the ideal location for research-oriented companies to develop their next groundbreaking or highly p...
News Feb 14, 2024 University of Fribourg discovers drug to combat age-related neuroinflammation Scientists at the University of Fribourg have uncovered a groundbreaking mechanism that could significantly mitigate age-related neuroinflammatio...
News Jan 12, 2022 ObsEva achieves positive results in the treatment of endometriosis Geneva-based women’s health biopharmaceutical company ObsEva has announced positive topline results from the Phase 3 EDELWEISS 3 trial of linzago...